GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lasa Supergenerics Ltd (NSE:LASA) » Definitions » EV-to-Revenue

Lasa Supergenerics (NSE:LASA) EV-to-Revenue : 1.30 (As of Jun. 25, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Lasa Supergenerics EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Lasa Supergenerics's enterprise value is ₹1,361 Mil. Lasa Supergenerics's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was ₹1,043 Mil. Therefore, Lasa Supergenerics's EV-to-Revenue for today is 1.30.

The historical rank and industry rank for Lasa Supergenerics's EV-to-Revenue or its related term are showing as below:

NSE:LASA' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.13   Med: 1.12   Max: 3.57
Current: 1.3

During the past 9 years, the highest EV-to-Revenue of Lasa Supergenerics was 3.57. The lowest was 0.13. And the median was 1.12.

NSE:LASA's EV-to-Revenue is ranked better than
70.17% of 1019 companies
in the Drug Manufacturers industry
Industry Median: 2.16 vs NSE:LASA: 1.30

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-06-25), Lasa Supergenerics's stock price is ₹23.16. Lasa Supergenerics's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ₹20.87. Therefore, Lasa Supergenerics's PS Ratio for today is 1.11.


Lasa Supergenerics EV-to-Revenue Historical Data

The historical data trend for Lasa Supergenerics's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lasa Supergenerics EV-to-Revenue Chart

Lasa Supergenerics Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only 0.97 1.28 1.26 0.86 1.25

Lasa Supergenerics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.86 0.84 1.06 1.28 1.25

Competitive Comparison of Lasa Supergenerics's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Lasa Supergenerics's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lasa Supergenerics's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Lasa Supergenerics's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Lasa Supergenerics's EV-to-Revenue falls into.



Lasa Supergenerics EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Lasa Supergenerics's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=1360.633/1043.35
=1.30

Lasa Supergenerics's current Enterprise Value is ₹1,361 Mil.
Lasa Supergenerics's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹1,043 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lasa Supergenerics  (NSE:LASA) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Lasa Supergenerics's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=23.16/20.868
=1.11

Lasa Supergenerics's share price for today is ₹23.16.
Lasa Supergenerics's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹20.87.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lasa Supergenerics EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Lasa Supergenerics's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Lasa Supergenerics (NSE:LASA) Business Description

Traded in Other Exchanges
Address
Andheri Kurla Road, Office No. 506 AND 507, 5th Floor Midas, Sahar Plaza, Andheri East, Mumbai, MH, IND, 400059
Lasa Supergenerics Ltd is engaged in the research, manufacturing, trading, producing, processing, preparing, and treating chemicals, API, Pharmaceuticals, drugs, and others. The company specializes in catalyst chemistry and manufactures anthelmintic and veterinary API products.

Lasa Supergenerics (NSE:LASA) Headlines

No Headlines